A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

Clinical trial NCT01012323 · COMPLETED

Trial details

NCT number: NCT01012323
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases

Start date: 2010-01-01
Primary completion: 2012-06-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.